Brief: MediPharm Labs Enters Cannabis Research Agreement With Keck School Of Medicine Of USC
09/08/2022 12:50
Aug 9 (Reuters) - MediPharm Labs Corp LABS.TO :
* MEDIPHARM LABS ENTERS CANNABIS RESEARCH AGREEMENT WITH
KECK
SCHOOL OF MEDICINE OF USC
Source text for Eikon: ID:nPn6dRWSva
Further company coverage: LABS.TO
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue